Study: Potential link between breast cancer genes, salivary gland cancer
October 21, 2014 -- Researchers have found a potential link between mutations in the BRCA1 and BRCA2 breast cancer genes and salivary gland cancer, according to a new study in JAMA Otolaryngology -- Head & Neck Surgery.
Study: Scientists discover cancer-fighting berry in Australia
October 16, 2014 -- An experimental drug derived from berries from an Australian rainforest tree appears to kill head and neck tumors, as well as melanomas, according to the authors of a new study in PLoS One.
FDA approves expanded indications for Lymphoseek
October 16, 2014 -- The U.S. Food and Drug Administration (FDA) has approved expanded indications for Navidea Biopharmaceuticals' Lymphoseek radiopharmaceutical agent.
ADA 2014: Friday highlights
October 13, 2014 -- SAN ANTONIO - The American Dental Association (ADA) 2014 annual meeting continued on Friday, with a crowded exhibit floor, dozens of continuing education offerings, and the presentation of more 2014 Dental Excellence Awards. Here are a few highlights from Friday.
Dental Excellence Awards 2014 winners
October 9, 2014 -- is pleased to announce the winners of the 2014 Dental Excellence Awards, recognizing the very best in people, products, and services that are helping to improve the dental industry. Awards are being handed out at this year's ADA 2014 annual meeting in San Antonio.
AGD Foundation to focus on oral cancer screening
October 8, 2014 -- The Academy of General Dentistry (AGD) Foundation, the philanthropic arm of the AGD, will focus on training dentists to screen for oral cancer.
ACD gets $1.4M to develop test for detecting non-Hodgkin lymphomas
October 8, 2014 -- Advanced Cell Diagnostics (ACD) has received a two-year $1.4 million grant from the National Cancer Institute (NCI) to develop and validate a diagnostic test for differentiating various B-cell non-Hodgkin lymphomas from benign lymphoproliferative diseases.
Tobacco use linked to oral HPV16 infection
October 7, 2014 -- Tobacco users have a higher prevalence of infection with oral human papillomavirus type 16 (HPV16), according to a new study in the Journal of the American Medical Association.
ESMO 2014: Afatinib improves progression-free survival in recurrent, metastatic HNC
September 30, 2014 -- The drug afatinib significantly improves progression-free survival in recurrent or metastatic head and neck cancer patients, according to a presentation at the 2014 European Society for Medical Oncology (ESMO) congress.
OralID will be available in Europe
September 30, 2014 -- Forward Science Technologies' oral cancer screening device, OralID, will be available in Europe this fall.
Special Feature
Aspirin can help battle head/neck cancer

Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer. Read more.

Dentifrices and Consumer Products
Dry Mouth Products
Tools and Instruments
Oral Cancer Detection